CL
NVO

CPWM LLC’s Novo Nordisk NVO Stock Holding History

CPWM LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.83M Sell
36,822
-944
-2% -$50.6K 0.17% 88
2022
Q2 		$2.1M Sell
37,766
-6,370
-14% -$353K 0.19% 89
2022
Q1 		$2.45M Sell
44,136
-3,768
-8% -$193K 0.18% 84
2021
Q4 		$2.3M Hold
47,904
– – 0.18% 81
2021
Q3 		$2.3M Sell
47,904
-5,922
-11% -$286K 0.21% 65
2021
Q2 		$2.25M Sell
53,826
-144
-0.3% -$5.58K 0.17% 67
2021
Q1 		$1.82M Sell
53,970
-4,996
-8% -$178K 0.16% 89
2020
Q4 		$2.06M Sell
58,966
-406
-0.7% -$14K 0.19% 85
2020
Q3 		$2.06M Sell
59,372
-4,644
-7% -$155K 0.22% 71
2020
Q2 		$2.1M Sell
64,016
-2,740
-4% -$87.4K 0.24% 67
2020
Q1 		$2.01M Sell
66,756
-2,500
-4% -$74.4K 0.29% 62
2019
Q4 		$2M Sell
69,256
-10,500
-13% -$291K 0.24% 73
2019
Q3 		$2.06M Buy
79,756
+70,000
+718% +$1.77M 0.27% 66
2019
Q2 		$249K Hold
9,756
– – 0.03% 236
2019
Q1 		$255K Sell
9,756
-822
-8% -$20.2K 0.04% 237
2018
Q4 		$244K Sell
10,578
-1,924
-15% -$42.8K 0.04% 209
2018
Q3 		$295K Sell
12,502
-6,092
-33% -$149K 0.04% 225
2018
Q2 		$429K Sell
18,594
-2,156
-10% -$51.2K 0.07% 191
2018
Q1 		$511K Buy
20,750
+584
+3% +$15.3K 0.08% 172
2017
Q4 		$541K Hold
20,166
– – 0.12% 114
2017
Q3 		$485K Sell
20,166
-1,974
-9% -$44.6K 0.11% 131
2017
Q2 		$475K Buy
22,140
+82
+0.4% +$1.66K 0.11% 134
2017
Q1 		$378K Hold
22,058
– – 0.09% 150
2016
Q4 		$395K Buy
22,058
+160
+0.7% +$2.9K 0.09% 152
2016
Q3 		$455K Sell
21,898
-2,846
-12% -$70.6K 0.1% 148
2016
Q2 		$665K Sell
24,744
-8,024
-24% -$220K 0.15% 106
2016
Q1 		$888K Sell
32,768
-1,024
-3% -$27.4K 0.19% 98
2015
Q4 		$981K Buy
+33,792
New +$935K 0.2% 90

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

CPWM LLC's NVO Position: Q3 2022 in Review

CPWM LLC reduced its Novo Nordisk (NVO) stake by 2.5% in Q3 2022, selling an estimated $50.6K and leaving 36,822 shares worth $1.83M. The position accounts for 0.17% of the portfolio, ranked #88.

CPWM LLC first reported a position in NVO in Q4 2015 and has held it in 28 quarters since. The position peaked at $2.45M in Q1 2022. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • CPWM LLC held 36,822 shares of Novo Nordisk worth $1.83M as of Q3 2022.
  • CPWM LLC sold 944 Novo Nordisk shares in Q3 2022, an estimated $50.6K.
  • Novo Nordisk made up 0.17% of CPWM LLC's portfolio in Q3 2022, its #88 holding.
  • CPWM LLC first reported a position in Novo Nordisk in Q4 2015 and has held it in 28 quarters since.
  • CPWM LLC's Novo Nordisk position peaked at $2.45M in Q1 2022.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.